会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Renin inhibiting polyhydroxy-monoamides
    • 肾素抑制多羟基 - 单酰胺
    • US5354767A
    • 1994-10-11
    • US990779
    • 1992-12-10
    • Paul C. AndersonGary W. BantleGrace L. JungPierre LavalleeBruno Simoneau
    • Paul C. AndersonGary W. BantleGrace L. JungPierre LavalleeBruno Simoneau
    • C07C235/08C07C235/26C07C235/34C07D233/54C07D233/88C07D277/36C07D307/58A61K31/16
    • C07D233/64C07C235/08C07C235/26C07C235/34C07D233/88C07D277/36C07D307/58C07C2101/02C07C2101/08C07C2101/14
    • Disclosed herein are compounds of the formula:R.sup.1 CH.sub.2 CH(X)CH(Y)CH(Z)CHR.sup.2 C(O)NHCHR.sup.3 CH(OH)CH(OH)R.sup.4wherein R.sup.1 is a terminal unit, for example lower cycloalkyl or phenyl; R.sup.2 is, for example, an optionally substituted alkyl, cycloalkylmethyl, benzyl, 4-imidazolylmethyl, 2-thienylmethyl or 4-thiazolylmethyl; R.sup.3 is alkyl, cycloalkylmethyl or an optionally substituted benzyl; R.sup.4 is alkyl or cycloalkyl; and X and Y each is hydroxy and Z is hydrogen, or X and Z each is hydroxy and Y is hydrogen; with the provisos that (a) the carbon atom bearing R.sup.2 has the "R" configuration except when R.sup.2 is 2-thienylmethyl or 2-thiazolylmethyl, X and Y each is hydroxy and Z is hydrogen, then the carbon atom bearing R.sup.2 has the "S" configuration; (b) the carbon atoms bearing R.sup.3 and R.sup.4 each has the "S" configuration; and (c) the carbon atom located between the last-said two carbon atoms has the "R" configuration. The compounds inhibit renin activity and are indicated for the treatment of hypertension and congestive heart failure.
    • 本文公开的是下式的化合物:R1CH2CH(X)CH(Y)CH(Z)CHR2C(O)NHCHR3CH(OH)CH(OH)R4其中R1是末端单元,例如低级环烷基或苯基; R2是例如任选取代的烷基,环烷基甲基,苄基,4-咪唑基甲基,2-噻吩基甲基或4-噻唑基甲基; R3是烷基,环烷基甲基或任选取代的苄基; R4是烷基或环烷基; X和Y各自为羟基,Z为氢,或X和Z各自为羟基,Y为氢; 条件是(a)带有R2的碳原子具有“R”构型,除非R2是2-噻吩基甲基或2-噻唑基甲基,X和Y各自为羟基,Z为氢,则带有R2的碳原子具有“ S“配置; (b)含有R 3和R 4的碳原子各自具有“S”构型; 和(c)位于最后所述两个碳原子之间的碳原子具有“R”构型。 该化合物抑制肾素活性,并被指示用于治疗高血压和充血性心力衰竭。